FHTX: Foghorn Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 179.63
Enterprise Value ($M) 124.17
Book Value ($M) -45.53
Book Value / Share -0.82
Price / Book -3.95
NCAV ($M) -79.91
NCAV / Share -1.44
Price / NCAV -2.25

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.34
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 3.73
Current Ratio 3.73

Balance Sheet (mrq) ($M)
Current Assets 249.60
Assets 283.98
Liabilities 329.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 22.60
Operating Income -100.28
Net Income -86.62

Cash Flow Statement (mra) ($M)
Cash From Operations -100.41
Cash from Investing -29.90
Cash from Financing 105.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A Fmr Llc 10.20 -9.73
10-08 13G/A Klarman Family Foundation 3.90
09-20 13G Flynn James E 5.31
05-30 13G Biotechnology Value Fund L P 9.99
05-24 13D/A Flagship Ventures Fund V, L.P. 22.90 28.64

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 23,872 62,122 38.43
2025-04-10 20,615 65,907 31.28
2025-04-09 41,978 177,132 23.70
2025-04-08 28,241 129,222 21.85
2025-04-07 84,134 256,037 32.86

(click for more detail)

Similar Companies
ETNB – 89bio, Inc. ETON – Eton Pharmaceuticals, Inc.
FATE – Fate Therapeutics, Inc. FOLD – Amicus Therapeutics, Inc.
FULC – Fulcrum Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io